Full Report - D. Western Therapeutics Institute (DWTI) (4576 JP)
The Company has already launched four products and is one of the few drug discovery ventures in Japan with a track record of commercial launches.
97 Views
D. Western Therapeutics Institute (4576 JP) - March 26, 2026
As part of this alliance, the Company will conduct a third-party allotment of new shares to Senju Pharmaceutical (scheduled for April 10), raising...
119 Views
D. Western Therapeutics Institute (DWTI) (4576 JP) - Q4 Follow-Up - March 3, 2026
The summary of full-year results for D. Western Therapeutics Institute (abbreviated as “DWTI,” hereinafter the “Company”) for FY2025/12 is as follows.
133 Views
D. Western Therapeutics Institute (DWTI) (4576 JP) - November 21, 2025
SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last year.
258 Views
News Flash: D. Western Therapeutics Institute (4576 JP) - November 5, 2025
DWTI announced after the close on 11/4 that 84.6% of the Series 13 Share Acquisition Rights (with exercise price adjustment clause) issued on July...
532 Views